Home › NDC Lookup › RxCUI directory › RxCUI 2392243

2 ML oliceridine 1 MG/ML Injection [Olinvyk] — RxCUI 2392243

RxNorm drug concept · Semantic branded drug
RxCUI 2392243 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2392243
Official name2 ML oliceridine 1 MG/ML Injection [Olinvyk]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as2 ML Olinvyk 1 MG/ML Injection; Olinvyk 2 MG in 2 ML Injection; 2 ML Olinvyk 1 MG/ML (as oliceridine fumarate 1.3 MG /1 ML) Injection; Olinvyk 2 MG per 2 ML Injection
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Oliceridine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Olinvyk is used in adults to control severe acute pain — the kind that's bad enough to need a strong opioid given directly into a vein. It's not for everyday or long-term pain. You...
  • Olinvyk works fast — most people notice some pain relief within 2 to 5 minutes of the first dose. It's given through an IV line only, never by mouth or any other route. Depending o...
  • How quickly will it start working, and how is it given?
  • The most common side effects are nausea, vomiting, dizziness, constipation, itching, headache, and feeling drowsy — these are typical opioid effects and your team will watch for th...
📖 Read our full Oliceridine Injection guide →

🕸️ Concept Web — How 2 ML oliceridine 1 MG/ML Injection [Olinvyk] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML oliceridine 1 MG/ML Injection [Olinvyk] RxCUI 2392243

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Oliceridine 2392230
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Olinvyk 2392235
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Oliceridine Injection 2618959
    • Oliceridine Injectable Product 2618958
    • Oliceridine Injection [Olinvyk] 2618963
    • Olinvyk Injectable Product 2392238
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 2 ML oliceridine 1 MG/ML Injection SCD · 2392242
  • Oliceridine 1 MG/ML SCDC · 2618957
  • Oliceridine Injection SCDF · 2618959
  • Oliceridine Injectable Product SCDG · 2618958

Brand-Name Concepts

  • Oliceridine 1 MG/ML [Olinvyk] SBDC · 2618962
  • Oliceridine Injection [Olinvyk] SBDF · 2618963
  • Olinvyk Injectable Product SBDG · 2392238
  • Olinvyk BN · 2392235

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2392243 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71308-0011-10 10 VIAL, SINGLE-DOSE in 1 CARTON (71308-011-10) / 1 mL in 1... OLINVYK Trevena, Inc. 2020-08-07
71308-0021-10 10 VIAL, SINGLE-DOSE in 1 CARTON (71308-021-10) / 2 mL in 1... OLINVYK Trevena, Inc. 2020-08-07
Observed labelers: Trevena, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.